Literature DB >> 8159434

Effects of Kelatorphan and morphine before and after noxious stimulation on immediate-early gene expression in rat spinal cord neurons.

Thomas R Tölle1, Jan Schadrack, Jose M Castro-Lopes, Gerard Evan, Bernard P Roques, Walter Zieglgänsberger.   

Abstract

Expression of the immediate-early genes (IEG) c-FOS, NGF1-A and c-JUN was induced by noxious thermal stimulation in neurons of the rat spinal cord dorsal horn. Intravenous injection of Kelatorphan (5, 10 and 20 mg/kg), an inhibitor of multiple enkephalin-degrading enzymes, 20 min before noxious stimulation reduced the overall number of dorsal horn neurons expressing c-FOS and NGF1-A by up to 20-30%. While c-FOS expression was suppressed in superficial and deep laminae of the spinal cord, NGF1-A and c-JUN was only suppressed in superficial laminae. Morphine (5, 7.5 and 10 mg/kg) produced a dose-dependent reduction of c-FOS expression by up to 70% only when injected before noxious stimulation. Morphine injected 10 min after the noxious treatment was virtually ineffective. The depressant effect of Kelatorphan and morphine could be prevented by prior application of the opioid antagonist naloxone. Naloxone itself slightly increased the overall number of c-FOS-positive neurons in all laminae of the spinal cord. The present data support the existence of a tonic release of endogenous opioid peptides at the spinal level and show that inhibition of their peptidase-induced degradation modulates IEG expression in dorsal horn neurons of the rat. The finding that opioid agonists were ineffective when applied after stimulation underline the necessity of pre-emptive analgesia to prevent long-term activity-dependent changes in spinal cord neurons.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8159434     DOI: 10.1016/0304-3959(94)90155-4

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  6 in total

1.  Aminophosphinic inhibitors as transition state analogues of enkephalin-degrading enzymes: a class of central analgesics.

Authors:  H Chen; F Noble; P Coric; M C Fournie-Zaluski; B P Roques
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

2.  Differential brainstem Fos-like immunoreactivity after laryngeal-induced coughing and its reduction by codeine.

Authors:  C Gestreau; A L Bianchi; L Grélot
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

3.  Intraplantar morphine depresses spinal c-Fos expression induced by carrageenin inflammation but not by noxious heat.

Authors:  P Honoré; J Buritova; J M Besson
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

4.  C-Fos expression in trigeminal nucleus neurons after chemical irritation of the cornea: reduction by selective blockade of nociceptor chemosensitivity.

Authors:  S Martinez; C Belmonte
Journal:  Exp Brain Res       Date:  1996-04       Impact factor: 1.972

Review 5.  [Physiology of pain].

Authors:  K Messlinger; H O Handwerker
Journal:  Schmerz       Date:  2015-10       Impact factor: 1.107

Review 6.  Association of enkephalin catabolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addiction.

Authors:  B P Roques; F Noble
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.